Utility of Biomarkers in Cardiac Amyloidosis Utility of Biomarkers in Cardiac Amyloidosis

This paper presents an overview of the utility of cardiac biomarkers in determining disease progression, response to therapies, and prognosis in patients with cardiac amyloidosis.JACC: Heart Failure
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news